Below you will find the posters for the conference.
Please click on the poster image to enlarge.
Assessment of risk factors associated with multidrug-resistant organism infections among patients admitted in a tertiary hospital - a retrospective study
A Targeted Antimicrobial Pharmacy Technician Ward Service Improves Stewardship and Patient-Centred Care and Safety of Commonly Prescribed Higher Risk Antimicrobials in the Acute Hospital Setting
Scale and Spread of a Quality Improvement Initiative Promoting Metronidazole Intravenous to Oral Switch (IVOST) in the Acute Hospital Setting: Antimicrobial Stewardship, Patient Safety,
Management Challenges and Treatment Options of Difficult to Treat Organisms in Patients with Complex Medical Devices: A Case of Vancomycin-Resistant Enterococcus Infection in a Patient with a Left Ventricular Assist Device
Study of Prescribing patterns and Effectiveness of Ceftolozane/Tazobactam Real-world Analysis (SPECTRA): Results on Critical Care Patients from a Multi-national, Multicenter, Observational Analysis
Novel Vancomycin Free Base – Sterosomes for Combating Staphylococcus Aureus and Methicillin-Resistant Staphylococcus Aureus (S. Aureus and MRSA) Infections.
Pharmacists' Knowledge, Attitudes, and Perceptions Towards Antimicrobial Stewardship and Resistance During the COVID-19 Pandemic at Secondary Care Settings in the UK
Systematic review assessing the impact of using McIsaac and Centor scores to aid antibiotic prescription decision making in patients presenting to secondary care with pharyngitis.
A phase 3 clinical study to evaluate the safety and immunogenicity of V116, an investigational adult-specific pneumococcal conjugate vaccine, in pneumococcal vaccine-experienced adults 50 years of age or older (STRIDE-6)
Phase 3 Randomized Study to Evaluate Lot-to-Lot Consistency, Safety, Tolerability, and Immunogenicity of V116 (Investigational Adult-Specific Pneumococcal Conjugate Vaccine) in Adults 18–49 Years of Age (STRIDE-4)
A phase 3 randomized study to evaluate safety, tolerability, and immunogenicity of V116, an investigational adult-specific pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in adults 50 years (STRIDE-5)
A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116, an Investigational Adult-Specific Pneumococcal Conjugate Vaccine, in Adults Living with HIV (STRIDE-7: Part A)
Immunogenicity of V116, an Investigational Adult-Specific Pneumococcal Conjugate Vaccine, in Pneumococcal Vaccine-Naïve Adults 50–64, 65–74, and ≥75 Years of Age: Subgroup Analysis of a Randomized Phase 3 Trial (STRIDE-3)
Efficacy and Safety of Gepotidacin for Uncomplicated Urinary Tract Infection: Pooled Subgroup Analyses of the EAGLE-2 and EAGLE-3 Randomised Phase 3 Trials
Impact of Regulatory Guidelines on Therapeutic, Clinical, and Microbiological Success Rates in Uncomplicated Urinary Tract Infection: Results from Two Phase 3 Randomised Controlled Trials of Oral Gepotidacin (EAGLE-2 and EAGLE-3)
Gepotidacin Efficacy in E. coli Drug-Resistant Phenotypes: A Pooled Analysis of the EAGLE-2 and EAGLE-3 Randomised Controlled Trials in Uncomplicated Urinary Tract Infection
CHARACTERISTICS OF PATHOGENS AND THEIR SENSITIVITY TO THE MAIN GROUPS OF ANTIBIOTICS IN PURULENT-INFLAMMATORY DISEASES OF SOFT TISSUES AND POSTOPERATIVE PURULENT COMPLICATIONS
Re-assessment of the primary efficacy outcomes of cefepime/enmetazobactam versus piperacillin/tazobactam in adult patients with complicated urinary tract infections or acute pyelonephritis using updated EUCAST piperacillin/tazobactam susceptibility breakpoints
Pharmacovigilance assessment of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) with Antibacterial drugs using Food and Drug Administration adverse event reporting system data
Treatment outcomes with rezafungin and caspofungin in adults with invasive candidiasis and/or candidaemia who had received no prior antifungal therapy: ReSTORE trial subgroup analysis
Once-weekly rezafungin versus daily caspofungin to treat candidaemia and invasive candidiasis: pooled analysis of clinical trial participants in Europe
The ReSPECT study design: comparison of once-weekly rezafungin against standard antimicrobial prophylaxis in adults undergoing allogeneic blood and marrow transplantation
An observational prospective audit on the use of vancomycin & ciprofloxacin in the treatment of severe community acquired pneumonia in penicillin allergic patients in NHS Lothian
Blood stream infection following Trans rectal ultrasound-guided prostate biopsy; antibiotic susceptibility of isolates relative to perioperative antibiotic prophylaxis regimen
